These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30974298)

  • 1. Design, synthesis and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Further optimization of selectivity towards HpIMPDH over human IMPDH2.
    Shah CP; Purushothaman G; Thiruvenkatam V; Kirubakaran S; Juvale K; Kharkar PS
    Bioorg Chem; 2019 Jun; 87():753-764. PubMed ID: 30974298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors.
    Sahu NU; Purushothaman G; Thiruvenkatam V; Kharkar PS
    Drug Dev Res; 2019 Feb; 80(1):125-132. PubMed ID: 30381846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, synthesis, and biological evaluation of sulfonyl-α-l-amino acids as potential anti-Helicobacter pylori and IMPDH inhibitors.
    Galal AMF; Mohamed HS; Abdel-Aziz MM; Hanna AG
    Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000385. PubMed ID: 33576040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and In Vitro Enzymatic Studies of New 3-Aryldiazenyl Indoles as Promising Helicobacter pylori IMPDH Inhibitors.
    Jangra S; Purushothaman G; Juvale K; Ravi S; Menon A; Thiruvenkatam V; Kirubakaran S
    Curr Top Med Chem; 2019; 19(5):376-382. PubMed ID: 30827248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
    Shah CP; Kharkar PS
    Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on Methylpyrazole-Substituted Benzimidazoles to Target
    Dilip H; Thiruvenkatam V; Kirubakaran S
    ACS Infect Dis; 2024 Jun; 10(6):2262-2275. PubMed ID: 38787329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection.
    Juvale K; Purushothaman G; Singh V; Shaik A; Ravi S; Thiruvenkatam V; Kirubakaran S
    Sci Rep; 2019 Jan; 9(1):190. PubMed ID: 30655593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
    Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.
    Hedstrom L; Liechti G; Goldberg JB; Gollapalli DR
    Curr Med Chem; 2011; 18(13):1909-18. PubMed ID: 21517780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irigenin, a novel lead from Iris confusa for management of Helicobacter pylori infection with selective COX-2 and HpIMPDH inhibitory potential.
    Abdel-Baki PM; El-Sherei MM; Khaleel AE; Abdel-Aziz MM; Okba MM
    Sci Rep; 2022 Jul; 12(1):11457. PubMed ID: 35794127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
    Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
    J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
    Nair V; Shu Q
    Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
    Shah CP; Kharkar PS
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):972-977. PubMed ID: 29792360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
    Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
    Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.
    Ni WW; Liu Q; Ren SZ; Li WY; Yi LL; Jing H; Sheng LX; Wan Q; Zhong PF; Fang HL; Ouyang H; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2018 Aug; 26(14):4145-4152. PubMed ID: 29983280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan Schiff bases-based polyelectrolyte complexes with graphene quantum dots and their prospective biomedical applications.
    Hamed AA; Saad GR; Abdelhamid IA; Elwahy AHM; Abdel-Aziz MM; Elsabee MZ
    Int J Biol Macromol; 2022 May; 208():1029-1045. PubMed ID: 35378157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel guanidine-based inhibitors of inosine monophosphate dehydrogenase.
    Iwanowicz EJ; Watterson SH; Liu C; Gu HH; Mitt T; Leftheris K; Barrish JC; Fleener CA; Rouleau K; Sherbina NZ; Hollenbaugh DL
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2931-4. PubMed ID: 12270177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and discovery of urease and Helicobacter pylori inhibitors based on benzofuran/benzothiophene-sulfonate and sulfamate scaffolds for the treatment of ureolytic bacterial infections.
    Hashem O; Zaib S; Zaraei SO; Javed H; Kedia RA; Anbar HS; Khan I; Ravi A; El-Gamal MI; Khoder G
    Int J Biol Macromol; 2024 Jun; 271(Pt 1):132502. PubMed ID: 38768915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening.
    Sarwono AEY; Mitsuhashi S; Kabir MHB; Shigetomi K; Okada T; Ohsaka F; Otsuguro S; Maenaka K; Igarashi M; Kato K; Ubukata M
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):171-178. PubMed ID: 30451014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
    Sintchak MD; Nimmesgern E
    Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.